Addus HomeCare (NASDAQ:ADUS – Get Free Report) announced its quarterly earnings data on Monday. The company reported $1.21 EPS for the quarter, topping analysts’ consensus estimates of $0.97 by $0.24, Briefing.com reports. The firm had revenue of $280.70 million during the quarter, compared to analyst estimates of $279.49 million. Addus HomeCare had a return on equity of 9.70% and a net margin of 5.91%. The company’s revenue was up 11.6% on a year-over-year basis. During the same period last year, the company earned $0.84 earnings per share.
Addus HomeCare Stock Performance
Shares of ADUS opened at $97.89 on Tuesday. Addus HomeCare has a twelve month low of $78.35 and a twelve month high of $104.61. The company has a debt-to-equity ratio of 0.18, a quick ratio of 1.38 and a current ratio of 1.38. The firm’s 50 day moving average price is $98.48 and its two-hundred day moving average price is $92.44. The firm has a market cap of $1.60 billion, a P/E ratio of 25.49, a PEG ratio of 1.94 and a beta of 0.96.
Wall Street Analysts Forecast Growth
Several equities analysts recently weighed in on ADUS shares. William Blair restated an “outperform” rating on shares of Addus HomeCare in a report on Monday, February 5th. Oppenheimer reaffirmed an “outperform” rating and set a $118.00 price objective on shares of Addus HomeCare in a research note on Tuesday, March 26th. Royal Bank of Canada restated an “outperform” rating and set a $102.00 target price on shares of Addus HomeCare in a report on Thursday, February 29th. Finally, Barclays downgraded shares of Addus HomeCare from an “equal weight” rating to an “underweight” rating and set a $83.00 price target on the stock. in a research report on Tuesday, April 23rd. One analyst has rated the stock with a sell rating and seven have given a buy rating to the company. According to MarketBeat.com, Addus HomeCare currently has an average rating of “Moderate Buy” and a consensus price target of $103.00.
About Addus HomeCare
Addus HomeCare Corporation, together with its subsidiaries, provides personal care services to elderly, chronically ill, disabled persons, and individuals who are at risk of hospitalization or institutionalization in the United States. The company operates through three segments: Personal Care, Hospice, and Home Health.
Featured Stories
- Five stocks we like better than Addus HomeCare
- 3 Must-Buy Warren Buffett Stocks for Volatile Times
- Lemonade Squeezes as Breakeven Date Gets Pulled Closer
- How to invest in marijuana stocks in 7 steps
- Tech Earnings Insights: Where Opportunity Meets Uncertainty
- 3 Monster Growth Stocks to Buy Now
- 3 CEO-Led Turnaround Stocks You Can Still Buy
Receive News & Ratings for Addus HomeCare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Addus HomeCare and related companies with MarketBeat.com's FREE daily email newsletter.